1Nociceptive pain is our _____ pain that's r/t some kind of _______ or _____ pain
- Acute
- Somatic (skin, bone, connective tissue)
- Visceral ( internal organs)
2Functional pain is d/t an abnormal presence of or inappropriate activation of the ______ w/in the _______
- Pain pathways
- Nervous system
3Opiates are the mainstay of _____ & _____ acute pain. It works on our _______ receptors to inhibit ________
- Moderate and severe
- Central opioid
- Pain pathways
4Morphine IV dose is _________ & continuous infusion dose is _______
- IV dose: 0.1 – 0.2 mg/kg IV q 3-4 hours
- 0.1 mg/kg/hr
5 Morphines duration is _____. It is assoc. w/ ______ & _______ release causing _____, _____, _____
- 3 to 5 hrs
- Hypotension
- Histamine
- Itchiness, flushing and redness
6Meperidine (Demerol®) is an opiate that has an active metabolite, _________, which is a ________. It's a poor choice for pt w/ ______ or hx of _______. Assoc. w/ ______ & _______
- Normeperidine
- CNS stimulant
- Renal dysfunction
- Seizures
- Dependance & Euphoria
7In most places, meperidine (Demerol®) for children is limited only to _________
Post operative trimmers
8Fentanyl can accumulate in the blood and cause a _______ effect or it can cause _______, meaning patients become _______ to it no matter how much you inc. the dose
- Compounding
- Tachyphylaxis
- Refractory
9Fentanyl has less _______ effects although is assoc with _________ & then chest wall rigidity when given to quickly
- Histamine effects
- Nasal pruritis
10PCA is used to control moderate-to-severe _______ pain, _____ pain, and _______ pain
- Post-operative
- Sickle cell
- Cancer
11Ketorolac (toradol): Limit IV use to ____ days due to ADR’s
5
12Etomidate (Amidate®) is an ultra short acting, non ______, _______ like compound that causes sedation. Not assoc. w/ _____ or ______
- Barbiturate
- Steroid
- Hypotension or inc. ICP
13Etomidate (Amidate®) is associated with _____, _____, ____, _____
Resp. depression, N/V, myoclonus and adrenal crisis
14Lorazepam (Ativan®) IV dose: ______ mg/kg/dose Q____ hours
- 0.05-0.1
- 6
15Lorazepam (Ativan®) has fewer _______ than other benzos, but it contains ______ that can be toxic to _____
- Drug interactions
- Preservatives
- Neonates
16Benzodiazepines potentiate ______ (neuro inhibitory transmitter) & have sedative, ________, ________ and anticonvulsant properties
- GABA
- Hypnotic
- Amnestic
17Dexmedetomidine (Precedex) is a __________ with potent sedative and mild analgesic properties
- Selective alpha-agonist
18Prior to procedure you need to obtain patients “AMPLE” history...This stands for
- Allergies
- Medications
- Past medical history
- Last meal
- Events leading up to scenario
19Pre-Sedation Evaluation includes ______, ______, & ______
Length of procedure; painful v. non-painful; location
20Minimum Fasting Time Period for clear liquids is ____ hrs; Breast milk is ____ hrs; Formula/milk is ____ hrs; & Solid foods is _____ hrs
- 2
- 4
- 6
- 8
21Depolarizing or agonist NMBA produces muscle paralysis through binding with ________, allowing for ________ and then paralysis
- Acetylcholine receptor
- Muscle contraction
22Non-depolarizing or antagonist NMBA produces muscle paralysis through ________ at the ________ receptor site and does not allow for _______
- Competitive binding
- Acetylcholine
- Depolarization
23Most common nerves used for TOF are the _____ & _____ nerves
Facial and ulnar
24Desired number of elicited twitches w/ TOF is at least _____
- ¼
25Pediatric patients receiving sedation and/or analgesic agents greater than or equal to ___ days are at risk for withdrawal
5
26Withdrawal is seen in 100% of pediatric patients receiving opioids or benzodiazepines for >___ days and will require a slow sedation taper
9
27Assessment tools for withdrawal include neonatal assessment scale for infants <____ old and the Withdrawal Assessment Tool (WAT) for ______
- 1 month
- Infants and children
28Patients who have received opioids or other sedative agents for _____ days, benefit from switching from IV agents to ______
- 5 days
- ATC long-acting oral agents
29If s/s of withdrawal are observed during the weaning process, an IV dose of “rescue” morphine _______ mg/kg or lorazepam ______ mg/kg should be given
- 0.05-0.1 mg/kg
- 0.05-0.1
30The most common adjunctive therapy to smooth sedation titration and minimize withdrawal is the use of _______
Clonidine
31Iatrogenic risk factors of delirium: sleep deprivation, _______, _______, ______, and psychoactive meds
Restraints, tubes/catheters, pain
32Long term outcomes of delirium: Inc. risk for psychological conditions (PTSD), _______, & _____
- Disorientation
- Language problems
33The neonatal infant pain scale tool evaluates _____, _____, & ______. It is used in patients < _______ & ranges from 0-7
- Respiratory pattern, facial expression, and level of alertness
- 1 y.o
34Opioid analgesics work on ______ opioid receptors including ____, ____, & ____ receptors. The predominant receptor is _____
- Central
- Mu, delta, and kappa
- Mu
35NSAIDs work by inhibiting _______, thereby blocking the production of ______ & _______
- COX (cyclooxygenase enzymes)
- Inflammatory cytokines and prostaglandins
36Signs of opioid overdose include respiratory depression, lethargy, ______, _____, _______ skin, and decreased level of consciousness
- Euphoria
- Pinpoint pupils (Miosis)
- Cool and clammy